LGX818

encorafenib · Novartis

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for LGX818, covering 2016-09-13 to 2024-10-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma [Phase 1]